13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 57 holding rows worth $1,318,974,000.
- Accession
- 0000921895-20-000569
- Filer
- CIK 1056807
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 57 entries on the cover page, a total value of $1,318,974,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,318,974,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,179,735 | $131,678,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,079,155 | $118,517,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 11,342,505 | $96,638,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 1,716,734 | $94,043,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 7,206,458 | $76,461,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 2,642,405 | $72,138,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 2,978,683 | $59,455,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 9,559,642 | $54,586,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 3,358,332 | $46,966,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 3,169,654 | $44,629,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 7,361,801 | $38,944,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 3,579,023 | $36,148,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 7,783,001 | $35,724,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,309,109 | $33,136,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,998,276 | $27,476,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,949,075 | $25,552,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 785,851 | $24,471,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 5,349,905 | $19,367,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 17,426,968 | $16,730,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 999,996 | $15,850,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,764,784 | $15,495,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 939,565 | $15,268,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 183,834 | $14,727,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,640,565 | $14,523,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 5,346,272 | $13,259,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 1,141,974 | $12,219,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 6,929,690 | $10,949,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,436,429 | $10,773,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 1,832,484 | $10,592,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 656,483 | $10,392,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 2,687,738 | $10,321,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 451,009 | $10,010,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,627,568 | $8,854,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 6,328,994 | $8,481,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 845,405 | $8,129,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,284,072 | $7,816,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,180,553 | $6,765,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 766,148 | $6,367,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 925,724 | $6,008,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 682,630 | $4,813,000 | thousands by filing date | |
| PHAXIAM THERAPEUTICS S A | 29604W108 | SPONSORED ADR | 625,000 | $4,550,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,137,764 | $4,369,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427401 | COMMON STOCK | 2,100,305 | $4,348,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 1,000,000 | $4,300,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 25,000 | $4,013,000 | thousands by filing date | |
| NULL | 09071M205 | NULL | 1,733,036 | $3,899,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 345,196 | $3,797,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 734,301 | $3,047,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 143,567 | $2,139,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 6,194,925 | $2,092,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,086,251 | $2,042,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 2,035,695 | $1,812,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 951,701 | $1,504,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 1,898,990 | $1,179,000 | thousands by filing date | |
| BRICKELL BIOTECH INC | 10802T105 | COM | 442,788 | $664,000 | thousands by filing date | |
| NOVUS THERAPEUTICS INC | 67011N105 | COM | 828,876 | $481,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 116,712 | $468,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-20-000569 | this filing | 2020-02-14 | acceptance time not in the bulk data set |